Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.297EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.597EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.581EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.422EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.125.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.78 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used